CLINICAL_TRIALS
trial_result
· 2023-12-28
Clinical Trial Update: FLYSYN in MRD Positive AML [Phase 1, Phase 2]
Summary
Clinical trial update for FLYSYN in MRD-positive acute myeloid leukemia completed phases 1 and 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Synimmune GmbH | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED